VP Pharma

René is a drug development executive with over 25 years of experience in drug discovery, pre-clinical and clinical drug development, medical devices, and life-cycle management across cardiovascular, respiratory, oncology, metabolic, CNS and rare genetic diseases.

After his specialization in clinical pharmacokinetics at Boehringer Ingelheim, he has successfully led multiple global cross-functional development programs from preclinical discovery through Phase 3 and regulatory approval at ALTANA Pharma (now Takeda), Actelion (now J&J) and Idorsia, including multiple IND filings and the submission and approval of three NDAs/MAAs in US, EU, Japan, and South Korea.

His expertise spans preclinical development, clinical development & biomarker strategy, orphan disease development, regulatory interactions, CMC, and commercialization strategies. He has significant experience in managing alliances, licensing opportunities, and cross-industry collaborations.

In his current function at DIAMANTE Biopharma, he provides strategic guidance and hands-on leadership for emerging companies.